Health & Personal Care
HIGH
FDA DRUG
Lannett Recalls Lisdexamfetamine Capsules Over Labeling Error
Lannett Company recalled 8,544 bottles of Lisdexamfetamine Dimesylate Capsules on August 11, 2025. The recall occurred due to a labeling mix-up where 40 mg capsules were mislabeled as 30 mg. This issue poses a high risk to consumers who may receive incorrect dosages.
Lisdexamfetamine Dimesylate
Labeling: Label